Moderate riskFDA DrugClass II

Golden State Medical Supply niacin extended-release tablets recalled for failed dissolution

Golden State Medical Supply is recalling specific lots of niacin extended-release tablets (1,000 mg) because they failed to dissolve properly during stability testing. The tablets did not meet dissolution specifications at the 24-hour mark, which means they may not release the medication as intended in the body.

From the FDA notice · Read the official notice ↗ · All Golden State Medical Supply recalls

What to do

  1. Check if you have niacin tablets from Golden State Medical Supply with lot numbers GS065128, GS065844, GS066695, GS067432, or GS067993 (expiring 01/31/2027).
  2. Do not stop taking niacin without talking to your doctor or pharmacist.
  3. Contact your pharmacist or Golden State Medical Supply to return or dispose of affected tablets.
  4. Talk to your doctor about getting a replacement prescription if needed.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
2,961 bottles
Illnesses reported
None reported
Manufactured in
5187 Camino Ruiz, N/A, Camarillo, CA, United States
Classification
Class II
Recall number
D-0587-2026

In the FDA's words

Description
GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90. Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint. Lots: GS065128, GS065844, GS066695, GS067432, GS067993, expires: 01/31/2027. Distribution: Within the U.S Market. Affected quantity: 2,961 bottles
Hazard
Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.

More from Golden State Medical Supply

See all

Related topics

PotencyDrugsSold nationwideMore from FDA Drug